"Kidney Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancers of the KIDNEY.
Descriptor ID |
D007680
|
MeSH Number(s) |
C04.588.945.947.535 C12.758.820.750 C12.777.419.473 C13.351.937.820.535 C13.351.968.419.473
|
Concept/Terms |
Kidney Neoplasms- Kidney Neoplasms
- Kidney Neoplasm
- Neoplasm, Kidney
- Renal Neoplasms
- Neoplasm, Renal
- Neoplasms, Renal
- Renal Neoplasm
- Neoplasms, Kidney
Cancer of Kidney- Cancer of Kidney
- Kidney Cancers
- Renal Cancer
- Cancer, Renal
- Cancers, Renal
- Renal Cancers
- Cancer of the Kidney
- Kidney Cancer
- Cancer, Kidney
- Cancers, Kidney
|
Below are MeSH descriptors whose meaning is more general than "Kidney Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Kidney Neoplasms".
This graph shows the total number of publications written about "Kidney Neoplasms" by people in this website by year, and whether "Kidney Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 17 | 1 | 18 |
1995 | 15 | 1 | 16 |
1996 | 19 | 3 | 22 |
1997 | 20 | 3 | 23 |
1998 | 14 | 3 | 17 |
1999 | 18 | 2 | 20 |
2000 | 11 | 4 | 15 |
2001 | 15 | 5 | 20 |
2002 | 22 | 6 | 28 |
2003 | 35 | 6 | 41 |
2004 | 24 | 7 | 31 |
2005 | 34 | 5 | 39 |
2006 | 39 | 2 | 41 |
2007 | 55 | 6 | 61 |
2008 | 66 | 9 | 75 |
2009 | 57 | 7 | 64 |
2010 | 69 | 7 | 76 |
2011 | 70 | 3 | 73 |
2012 | 64 | 5 | 69 |
2013 | 61 | 6 | 67 |
2014 | 69 | 8 | 77 |
2015 | 76 | 2 | 78 |
2016 | 70 | 6 | 76 |
2017 | 74 | 2 | 76 |
2018 | 50 | 4 | 54 |
2019 | 48 | 2 | 50 |
2020 | 59 | 4 | 63 |
2021 | 56 | 3 | 59 |
2022 | 39 | 0 | 39 |
2023 | 62 | 0 | 62 |
2024 | 5 | 0 | 5 |
To return to the timeline,
click here.
Below are the most recent publications written about "Kidney Neoplasms" by people in Profiles.
-
YIA24-001: Spatial Evolution of Immune Cell Dysfunction During Development of Oligometastatic Renal Cell Carcinoma: Secondary Analysis of a Prospective Trial. J Natl Compr Canc Netw. 2024 Apr 05; 22(2.5).
-
ASPSCR1-TFE3 reprograms transcription by organizing enhancer loops around hexameric VCP/p97. Nat Commun. 2024 Feb 07; 15(1):1165.
-
Locoregional Therapies in Immunologically "Cold" Tumors: Opportunities and Clinical Trial Design Considerations. J Vasc Interv Radiol. 2024 Feb; 35(2):198-202.
-
NCCN Guidelines? Insights: Kidney Cancer, Version 2.2024. J Natl Compr Canc Netw. 2024 02; 22(1):4-16.
-
TFEB drives mTORC1 hyperactivation and kidney disease in Tuberous Sclerosis Complex. Nat Commun. 2024 Jan 09; 15(1):406.
-
A phase 2, multicenter, open-label study of anti-LAG-3 ieramilimab in combination with anti-PD-1 spartalizumab in patients with advanced solid malignancies. Oncoimmunology. 2024; 13(1):2290787.
-
Genetic and epigenetic features of bilateral Wilms tumor predisposition in patients from the Children's Oncology Group AREN18B5-Q. Nat Commun. 2023 Dec 18; 14(1):8006.
-
Combining the Tyrosine Kinase Inhibitor Cabozantinib and the mTORC1/2 Inhibitor Sapanisertib Blocks ERK Pathway Activity and Suppresses Tumor Growth in Renal Cell Carcinoma. Cancer Res. 2023 12 15; 83(24):4161-4178.
-
Delineating the interplay between oncogenic pathways and immunity in anaplastic Wilms tumors. Nat Commun. 2023 Nov 30; 14(1):7884.
-
Contemporary Issues in Urothelial Carcinoma of Upper Urinary Tract. Adv Anat Pathol. 2024 Mar 01; 31(2):80-87.